Breaking News, Collaborations & Alliances

Ryvu Therapeutics to Support Clinical Trials for BioNTech in Poland

Will support BioNTech in the acceleration of site activation and enrollment of patients for multiple of BioNTech’s priority oncology clinical programs in Poland.

Author Image

By: Charlie Sternberg

Associate Editor

Ryvu Therapeutics, a clinical-stage drug discovery and development company specializing in novel therapies targeting emerging oncology targets, is entering a strategic partnership with BioNTech to benefit Polish cancer patients by providing support for trial site activation and patient recruitment for multiple investigational immunotherapies within BioNTech’s oncology pipeline in Poland. Ryvu’s operational excellence, expertise in oncology clinical operations, and existing trial site network ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters